<DOC>
	<DOC>NCT01685736</DOC>
	<brief_summary>Subjects referred to a sleep clinic had polysomnography (PSG), clinic BP measurements, 24-hour ABP monitoring and HBP monitoring using a device (Microlife WatchBP HomeN) that allows daytime (3 days, 2 duplicate readings/day) and automated nighttime BP measurement (3 nights, 3 readings/night).</brief_summary>
	<brief_title>Ambulatory Versus Home Blood Pressure Monitoring in Obstructive Sleep Apnea</brief_title>
	<detailed_description />
	<mesh_term>Apnea</mesh_term>
	<mesh_term>Sleep Apnea Syndromes</mesh_term>
	<mesh_term>Sleep Apnea, Obstructive</mesh_term>
	<criteria>Age â‰¤ 65 years Suspected OSA Treated or untreated for hypertension History of cardiovascular disease (heart failure, coronary heart disease, arrhythmia or stroke) History of asthma or chronic obstructive pulmonary disease (FEV1/FVC &lt;70%) History of diabetes mellitus, collagen diseases and sarcoidosis Serum creatinine &gt;1.6 mg/dl, proteinuria Previous treatment with CPAP Pregnancy or menstruation during the study Treatment with steroids, lithium or any other drugs affecting BP Change in antihypertensive treatment(if any) in the last 8 weeks before study entry</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>September 2012</verification_date>
</DOC>